ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Reaches Consensus On Organ Systems; DeVita Goes Along

February 4, 1983

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997